solyrna.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-Agent: * Disallow: /tilda/form* Disallow: /tilda/rec* Disallow: /tilda/click* Disallow: /tilda/scroll* Disallow: /tilda/popup* Disallow: /tilda/cart* Disallow: /tilda/product* Disallow: /tilda/event* Disallow: /*_escaped_fragment_* Disallow: Sitemap: http://solyrna.com/sitemap.xml Host: | ||
Meta Tags
| Title | SOLYRNA |
| Description | RNA solution for protein solubility inspired by Nature. Novel Custom RNA-Based Formulations for Solubilizing Therapeutic Proteins. Contact us Antibodies a |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 198.50.252.64 |
| Location | Canada |
Related Websites
| Site | Rank |
More to Explore
solyrna.com Valuation
|
US$1,737
Last updated: 2023-05-20 00:47:13
solyrna.com has Semrush global rank of 0. solyrna.com has an estimated worth of US$ 1,737, based on its estimated Ads revenue. solyrna.com receives approximately 200 unique visitors each day. Its web server is located in Canada, with IP address 198.50.252.64. According to SiteAdvisor, solyrna.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,737 |
| Daily Ads Revenue | US$1 |
| Monthly Ads Revenue | US$48 |
| Yearly Ads Revenue | US$577 |
| Daily Unique Visitors | 13 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| solyrna.com. | A | 7199 | IP: 198.50.252.64 |
| solyrna.com. | NS | 86400 | NS Record: ns2.onlydomains.com. |
| solyrna.com. | NS | 86400 | NS Record: ns1.onlydomains.com. |
| solyrna.com. | NS | 86400 | NS Record: ns3.onlydomains.com. |
| solyrna.com. | MX | 86400 | MX Record: 10 mail.solyrna.com. |
HtmlToTextCheckTime:2023-05-20 00:47:13
| RNA solution for protein solubility inspired by Nature. Novel Custom RNA-Based Formulations for Solubilizing Therapeutic Proteins. Contact us Antibodies and other proteins represent a multi-billion-dollar medicinal market. However, proteins often have to be administered at high concentrations, which is difficult because proteins tend to aggregate or clump together under these conditions. Protein aggregates limit therapy efficacy and can be a health risk. The main scope of the technology is developing formulations for highly-concentrated therapeutic proteins, including monoclonal and polyclonal antibodies, whereby rationally designed RNA oligonucleotides are used to control protein solubility, aggregation, and viscosity in a targeted manner. To deliver a game-changing technology – RNA-based formulations for biologicals, designed using a novel systematic & rationally based frameworks. *all-atom modeling Scientific background SOLYRNA technology is the result of years of fundamental |
solyrna.com Whois Information
Domain Name: SOLYRNA.COM Registry Domain ID: 2361772826_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.instra.net Registrar URL: http://www.instra.com Updated Date: 2021-02-08T16:00:04Z Creation Date: 2019-02-18T14:09:22Z Registry Expiry Date: 2023-02-18T14:09:22Z Registrar: Instra Corporation Pty Ltd. Registrar IANA ID: 1376 Registrar Abuse Contact Email: abuse@instra.com Registrar Abuse Contact Phone: +61.397831800 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.ONLYDOMAINS.COM Name Server: NS2.ONLYDOMAINS.COM Name Server: NS3.ONLYDOMAINS.COM DNSSEC: unsigned >>> Last update of whois database: 2022-12-16T08:55:04Z <<< |